The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model
Open accessAbstract
Disablement of cell death programs in cancer cells contributes to drug resistance and in some cases has been associated with altered translational control. As eukaryotic translation initiation factor 4E (eIF4E) cooperates with c-Myc during lymphomagenesis, induces drug resistance, and is a genetic modifier of the rapamycin response, we have investigated the effect of dysregulation of the ribosome recruitment phase of translation initiation on tumor progression and chemosensitivity. eIF4E is a subunit of eIF4F, a complex that stimulates ribosome recruitment during translation initiation by delivering the DEAD-box RNA helicase eIF4A to the 5' end of mRNAs. eIF4A is thought to prepare a ribosome landing pad on mRNA templates for incoming 40S ribosomes (and associated factors). Using small molecule screening, we found that cyclopenta[b]benzofuran flavaglines, a class of natural products, modulate eIF4A activity and inhibit translation initiation. One member of this class of compounds, silvestrol, was able to enhance chemosensitivity in a mouse lymphoma model in which carcinogenesis is driven by phosphatase and tensin homolog (PTEN) inactivation or elevated eIF4E levels. These results establish that targeting translation initiation can restore drug sensitivity in vivo and provide an approach to modulating chemosensitivity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
O'Reilly, K. E., Rojo, F., She, Q.-B., Solit, D., Mills, G. B., Smith, D., Lane, H., Hofmann, F., Hicklin, D. J., Ludwig, D. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2925 · Cited by 2,561
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365
Current development of mTOR inhibitors as anticancer agents
Faivre, S., Kroemer, G., & Raymond, E. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2062 · Cited by 1,000
Jurica, M. S., & Moore, M. J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00270-3 · Cited by 962
Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap
Lazaris-Karatzas, A., Montine, K. S., & Sonenberg, N. (1990) · Nature · doi:10.1038/345544a0 · Cited by 956
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy
Wendel, H.-G., Stanchina, E. D., Fridman, J. S., Malina, A., Ray, S., Kogan, S., Cordon-Cardo, C., Pelletier, J., & Lowe, S. W. (2004) · Nature · doi:10.1038/nature02369 · Cited by 951
Self-citationDEAD-box proteins: the driving forces behind RNA metabolism
Rocak, S., & Linder, P. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1335 · Cited by 772
Molecular mechanisms of translation initiation in eukaryotes
Pestova, T. V., Kolupaeva, V. G., Lomakin, I. B., Pilipenko, E. V., Shatsky, I. N., Agol, V. I., & Hellen, C. U. T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111145798 · Cited by 742
S6K1- and ßTRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell Growth
Dorrello, N. V., Peschiaroli, A., Guardavaccaro, D., Colburn, N. H., Sherman, N. E., & Pagano, M. (2006) · Science · doi:10.1126/science.1130276 · Cited by 731
Translational control in biology and medicine
Mathews, M. B., Sonenberg, N., & Hershey, J. W. B. (2007) · Cited by 661
The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis
Ruggero, D., Montanaro, L., Ma, L., Xu, W., Londei, P., Cordon-Cardo, C., & Pandolfi, P. P. (2004) · Nature Medicine · doi:10.1038/nm1042 · Cited by 586
Yang, H.-S., Jansen, A. P., Komar, A. A., Zheng, X., Merrick, W. C., Costes, S., Lockett, S. J., Sonenberg, N., & Colburn, N. H. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.26-37.2003 · Cited by 494
SVITKIN, Y. V., PAUSE, A., HAGHIGHAT, A., PYRONNET, S., WITHERELL, G., BELSHAM, G. J., & SONENBERG, N. (2001) · RNA · doi:10.1017/s135583820100108x · Cited by 477
Rajasekhar, V. K., Viale, A., Socci, N. D., Wiedmann, M., Hu, X., & Holland, E. C. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00395-2 · Cited by 420
Pause, A., Méthot, N., Svitkin, Y., Merrick, W. C., & Sonenberg, N. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06370.x · Cited by 393
XIAP: Apoptotic brake and promising therapeutic target
Holcik, M., Gibson, H., & Korneluk, R. G. (2001) · Apoptosis · doi:10.1023/a:1011379307472 · Cited by 385
Graff, J. R., Konicek, B. W., Vincent, T. M., Lynch, R. L., Monteith, D., Weir, S. N., Schwier, P., Capen, A., Goode, R. L., Dowless, M. S., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32044 · Cited by 380
Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4A
Bordeleau, M.-E., Mori, A., Oberer, M., Lindqvist, L., Chard, L. S., Higa, T., Belsham, G. J., Wagner, G., Tanaka, J., & Pelletier, J. (2006) · Nature Chemical Biology · doi:10.1038/nchembio776 · Cited by 366
Self-citationRapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML
Zeng, Z., Sarbassov, D. D., Samudio, I. J., Yee, K. W. L., Munsell, M. F., Ellen Jackson, C., Giles, F. J., Sabatini, D. M., Andreeff, M., & Konopleva, M. (2007) · Blood · doi:10.1182/blood-2006-06-030833 · Cited by 342
Avdulov, S., Li, S., Michalek, V., Burrichter, D., Peterson, M., Perlman, D. M., Manivel, J. C., Sonenberg, N., Yee, D., Bitterman, P. B., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.05.024 · Cited by 340
Inhibitors of protein biosynthesis
(2006) · Biochemistry and Molecular Biology of Antimicrobial Drug Action · doi:10.1007/0-387-27566-5_5 · Cited by 318
Inhibitors of Protein Biosynthesis
Grollman, A. P. (1967) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)95953-3 · Cited by 292
Bordeleau, M.-E., Matthews, J., Wojnar, J. M., Lindqvist, L., Novac, O., Jankowsky, E., Sonenberg, N., Northcote, P., Teesdale-Spittle, P., & Pelletier, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504249102 · Cited by 228
Self-citationEpigenetic Activation of a Subset of mRNAs by eIF4E Explains Its Effects on Cell Proliferation
Mamane, Y., Petroulakis, E., Martineau, Y., Sato, T.-A., Larsson, O., Rajasekhar, V. K., & Sonenberg, N. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000242 · Cited by 224
Involvement of eukaryotic initiation factor 4A in the cap recognition process.
Edery, I., Hümbelin, M., Darveau, A., Lee, K. A., Milburn, S., Hershey, J. W., Trachsel, H., & Sonenberg, N. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44431-0 · Cited by 221
The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth.
Rousseau, D. L., Gingras, A., Pause, A., & Sonenberg, N. (1996) · PubMed · Cited by 220
Dendritic BC1 RNA: Functional Role in Regulation of Translation Initiation
Wang, H., Iacoangeli, A., Popp, S., Muslimov, I. A., Imataka, H., Sonenberg, N., Lomakin, I. B., & Tiedge, H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-23-10232.2002 · Cited by 220
Epidermal Expression of the Translation Inhibitor Programmed Cell Death 4 Suppresses Tumorigenesis
Jansen, A. P., Camalier, C. E., & Colburn, N. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2119 · Cited by 212
Zhang, L., Pan, X., & Hershey, J. W. B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606284200 · Cited by 204
Silvestrol and Episilvestrol, Potential Anticancer Rocaglate Derivatives from Aglaia silvestris
Hwang, B. Y., Su, B.-N., Chai, H., Mi, Q., Kardono, L. B. S., Afriastini, J. J., Riswan, S., Santarsiero, B. D., Mesecar, A. D., Wild, R., et al. (2004) · The Journal of Organic Chemistry · doi:10.1021/jo040120f · Cited by 193
Grolleau, A., Bowman, J., Pradet-Balade, B., Puravs, E., Hanash, S., Garcia-Sanz, J. A., & Beretta, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202014200 · Cited by 187
Polunovsky, V. A., Rosenwald, I. B., Tan, A. T., White, J., Chiang, L., Sonenberg, N., & Bitterman, P. B. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6573 · Cited by 165
RNA-Mediated Sequestration of the RNA Helicase eIF4A by Pateamine A Inhibits Translation Initiation
Bordeleau, M.-E., Cencic, R., Lindqvist, L., Oberer, M., Northcote, P., Wagner, G., & Pelletier, J. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.10.005 · Cited by 161
Self-citationMalignant transformation by overproduction of translation initiation factor eIF4G.
Shimogori, T., Ishii, I., Kashiwagi, K., Mashiba, H., EKIMOTO, H., & Igarashi, K. (1997) · PubMed · Cited by 159
Enhanced expression of translation factor mRNAs in hepatocellular carcinoma.
Shuda, M., Kondoh, N., Tanaka, K., Ryo, A., Wakatsuki, T., Hada, A., Goseki, N., Igari, T., Hatsuse, K., Aihara, T., et al. (2000) · PubMed · Cited by 159
Benedetti, A. D., Joshi‐Barve, S., Rinker-Schaeffer, C. W., & Rhoads, R. E. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.11.5435-5445.1991 · Cited by 157
Dendritic BC1 RNA in translational control mechanisms
Wang, H., Iacoangeli, A., Lin, D., Williams, K. L., Denman, R. B., Hellen, C. U. T., & Tiedge, H. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200506006 · Cited by 155
Gerard, B., Sangji, S., O’Leary, D. J., & Porco, J. A. J. (2006) · Journal of the American Chemical Society · doi:10.1021/ja062621j · Cited by 149
Self-citationATP/Mg++-dependent cross-linking of cap binding proteins to the 5′ end of eukaryotic mRNA
Sonenberg, N. (1981) · Nucleic Acids Research · doi:10.1093/nar/9.7.1643 · Cited by 145
Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinoma
Li, B. D. �., Liu, L., Dawson, M., & Benedetti, A. D. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970615)79:12<2385::aid-cncr13>3.0.co;2-n · Cited by 141
The p46 subunit of eukaryotic initiation factor (eIF)-4F exchanges with eIF-4A.
Yoder-Hill, J., Pause, A., Sonenberg, N., & Merrick, W. C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53358-5 · Cited by 140
Potential of Cyclopenta[b]benzofurans from Aglaia Species in Cancer Chemotherapy
Kim, S.-Y., Salim, A. A., Swanson, S., & Kinghorn, A. D. (2006) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152006777698123 · Cited by 140
Inhibitors of protein synthesis identified by a high throughput multiplexed translation screen
Novac, O., Guenier, A.-S., & Pelletier, J. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh235 · Cited by 139
Self-citationThe role of translation in neoplastic transformation from a pathologist's point of view
Rosenwald, I. B. (2004) · Oncogene · doi:10.1038/sj.onc.1207552 · Cited by 139
Eberle, J., Krasagakis, K., & Orfanos, C. E. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970502)71:3<396::aid-ijc16>3.0.co;2-e · Cited by 137
Lee, S. K., Cui, B., Mehta, R. R., Kinghorn, A. D., & Pezzuto, J. M. (1998) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(98)00073-8 · Cited by 137
Jansen, A. P., Camalier, C. E., Stark, C., & Colburn, N. H. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.103.3.2 · Cited by 132
6 Regulation of Ribosomal Recruitment in EukaryotesPreprint
Raught, B., Gingras, A., & Sonenberg, N. (2000) · Cold Spring Harbor Monograph Archive · doi:10.1101/087969618.39.245 · Cited by 117
Translational Control of the Antiapoptotic Function of Ras
Polunovsky, V. A., Gingras, A., Sonenberg, N., Peterson, M., Tan, A., Rubins, J. B., Manivel, J. C., & Bitterman, P. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001938200 · Cited by 117
Li, S., Takasu, T., Perlman, D., Peterson, M. S., Burrichter, D., Avdulov, S. V., Bitterman, P. B., & Polunovsky, V. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208821200 · Cited by 115
Rocaglamide Derivatives Are Potent Inhibitors of NF-κB Activation in T-cells
Baumann, B., Bohnenstengel, F. I., Siegmund, D., Wajant, H., Weber, C. K., Herr, I., Debatin, K., Proksch, P., & Wirth, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208003200 · Cited by 111
Tan, A., Bitterman, P. B., Sonenberg, N., Peterson, M., & Polunovsky, V. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203446 · Cited by 110
Determinants of Sensitivity and Resistance to Rapamycin-Chemotherapy Drug Combinations In vivo
Wendel, H., Malina, A., Zhao, Z., Zender, L., Kogan, S. C., Cordon‐Cardo, C., Pelletier, J., & Lowe, S. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0419 · Cited by 108
Self-citationLi, S., Sonenberg, N., Gingras, A., Peterson, M., Avdulov, S. V., Polunovsky, V. A., & Bitterman, P. B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2853-2861.2002 · Cited by 100
Kim, S.-Y., Hwang, B. Y., Su, B., Chai, H., Mi, Q., Kinghorn, A. D., Wild, R., & Swanson, S. M. (2007) · PubMed · Cited by 95
Rocaglamide Derivatives Are Immunosuppressive Phytochemicals That Target NF-AT Activity in T Cells
Proksch, P., Giaisi, M., Treiber, M. K., Pálfi, K., Merling, A., Spring, H., Krammer, P. H., & Li‐Weber, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.7075 · Cited by 74
Cyclopentabenzofuran Lignan Protein Synthesis Inhibitors from Aglaia odorata
Ohse, T., Ohba, S., Yamamoto, T., Koyano, T., & Umezawa, K. (1996) · Journal of Natural Products · doi:10.1021/np960346g · Cited by 74
Larsson, O. S., Perlman, D., Fan, D., Reilly, C., Peterson, M., Dahlgren, C., Liang, Z., Li, S., Polunovsky, V. A., Wahlestedt, C., et al. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl558 · Cited by 64
Silvestrol regulates G2/M checkpoint genes independent of p53 activity.
Mi, Q., Kim, S. Y., Hwang, B. Y., Su, B.-N., Chai, H., Arbieva, Z. H., Kinghorn, A. D., & Swanson, S. M. (2006) · PubMed · Cited by 60
Hausott, B., Greger, H., & Marian, B. (2004) · International Journal of Cancer · doi:10.1002/ijc.20033 · Cited by 48
Self-citation15 Translational Control in Cancer Development and ProgressionPreprint
Schneider, R. J., & Sonenberg, N. (2007) · Cold Spring Harbor Monograph Archive · doi:10.1101/087969767.48.401 · Cited by 39
Rocaglaol induces apoptosis and cell cycle arrest in LNCaP cells.
Mi, Q., Su, B.-N., Chai, H., Cordell, G. A., Farnsworth, N. R., Kinghorn, A. D., & Swanson, S. M. (2006) · PubMed · Cited by 25
Research works printed but not linked: 11
- Raught, B., Gingras, A.-C., and Sonenberg, N. 2000.Regulation of ribosome recruitment in eukaryotes. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, New York, USA. 245–293.
- Fukuchi-Shimogori, 1997, Cancer Res., 57, 5041
- Rousseau, 1996, Oncogene., 13, 2415
- De Benedetti, 1991, Mol. Cell. Biol., 11, 5435, 10.1128/MCB.11.11.5435 · doi:10.1128/mcb.11.11.5435
- 10.1021/np060428x · doi:10.1021/np060428x
- Mi, 2006, Anticancer Res., 26, 947
- Mi, 2006, Anticancer Res., 26, 3349
- Shuda, 2000, Anticancer Res., 20, 2489
- 10.1016/S1357-2725(00)00007-8 · doi:10.1016/s1357-2725(00)00007-8
- Kim, 2007, Anticancer Res., 27, 2175
- 10.1016/S0031-9422(00)00471-4 · doi:10.1016/s0031-9422(00)00471-4
Cited by
Functional 5′ UTR mRNA structures in eukaryotic translation regulation and how to find them
Leppek, K., Das, R., & Barna, M. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.103 · Cited by 949
Translational control in cancer
Silvera, D., Formenti, S. C., & Schneider, R. J. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2824 · Cited by 821
Targeting the translation machinery in cancer
Bhat, M., Robichaud, N., Hulea, L., Sonenberg, N., Pelletier, J., & Topisirovic, I. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4505 · Cited by 799
Self-citationRNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer
Wolfe, A. L., Singh, K., Zhong, Y., Drewe, P., Rajasekhar, V. K., Sanghvi, V. R., Mavrakis, K. J., Jiang, M., Roderick, J. E., Van der Meulen, J., et al. (2014) · Nature · doi:10.1038/nature13485 · Cited by 635
Self-citationFor better or for worse: the role of Pim oncogenes in tumorigenesis
Nawijn, M. C., Alendar, A., & Berns, A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2986 · Cited by 481
Metadata
- Authors
- Bordeleau, M.-E., Robert, F., Gerard, B., Lindqvist, L., Chen, S. M. H., Wendel, H.-G., Brem, B., Greger, H., Lowe, S. W., Porco, J. A., & Pelletier, J.
- Venue
- Journal of Clinical Investigation
- Published
- 2008-06-01
- Volume
- 118
- Issue
- 7
- Pages
- 2651-60
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2030802073
- Cited by
- 332
- References
- 63
- FWCI
- 6.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.